Great New Low Dose Naltrexone (LDN) Science Site

A brilliant one-stop resource for scientific information on Low Dose Naltrexone (LDN).
A good one to give to skeptical doctors.

There's a newsletter you can sign up to too.

http://www.ldnscience.org

NEW European Parliament Level Petition for Low Dose Naltrexone Research Funding

Please consider signing this petition and passing it on.

NOTE - NO donation is required to the petition site, after filling in your details on the first page you have signed the petition and can leave the site without donating. Any donations that are made do not go to LDN Now or the EU government but rather to the petitions site.

NOTE - This petition is open to anyone, anywhere, not just EU citizens.

Thanks.

http://www.ipetitions.com/petition/ldnnow/

UK Government Response to the LDN Now 13,000 Signature NHS Low Dose Naltrexone Trial Petition to Gordon Brown, UK Prime Minister, Gordon Brown

Link - http://www.number10.gov.uk/Page21825

Text -

All drugs need to be thoroughly tested to make sure they are safe enough to be made available to patients. Most research of this kind is done by the pharmaceutical industry. The Government is aware that occasionally there will be few or no commercial incentives for companies to fund clinical trials.

The Department of Health’s National Institute for Health Research (NIHR) supports the research most likely to bring benefits to patients and to the NHS. High quality proposals for support into any aspect of human health are always welcome. The NIHR Health Technology Assessment programme in particular is keen to receive suggestions for research topics in areas of market failure. These can be sent through the open access form at: www.hta.ac.uk/suggest/index.shtml.

To date, no application has been received regarding low dose naltrexone. Any application would be considered on its merits.

----

Author's Note - There is reason to suspect the sbove is not factually correct and that one application has been made. More news to follow later.

Audit Scotland Warns of Pressures on the NHS Scotland Budget - Low Dose Naltrexone (LDN) Savings Cannot Be Ignored

And so it goes on, yet another reason why the 4000%+ higher price of currently used auto-immune and cancer treatments vs Low Dose Naltrexone (LDN) cannot be ignored any longer. The potential billions of pounds in savings here make the millions required for LDN clinical trials a sound investment for the NHS in Scotland and the UK as a whole.

http://bit.ly/SPLDNcost